Double-enzyme coupling recombinant bacteria of 3-ketosteroid 9alpha-hydroxylase and application of double-enzyme coupling recombinant bacteria in preparation of steroid drugs
By constructing a dual enzyme-coupled recombinant bacteria of 3-ketosteroid 9α-hydroxylase, the gene expression and coenzyme regeneration strategy are optimized, and combined with high-density fermentation and substrate feeding strategies, the problems of low catalytic efficiency and high cost of the steroid compound 9α-OH-AD are solved, and efficient and stable biocatalytic synthesis is achieved, providing a feasible solution for the industrial production of steroid drugs.
Patent Information
- Application Number
- CN202510331548.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-20
- Publication Date
- 2025-07-04
AI Technical Summary
The microbial catalytic synthesis of the existing steroid compound 9α-OH-AD has problems such as low catalytic efficiency, high coenzyme cost, and high substrate concentration inhibition of enzyme activity, making it difficult to achieve industrial application.
By constructing a dual enzyme-coupled recombinant bacteria of 3-ketosteroid 9α-hydroxylase, the gene expression system, coenzyme NADH regeneration strategy and high-density fermentation combined with substrate feeding strategy are optimized to improve catalytic efficiency and reduce costs.
The efficient biocatalytic synthesis of 9α-OH-AD was achieved, with a catalytic conversion rate of 98.3%, which significantly improved production efficiency, reduced catalytic costs, adapted to high substrate concentration, and had industrial application prospects.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
(1) Technical Field
[0001] The present invention belongs to the technical field of biocatalysis and synthesis, and particularly relates to a dual-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase and its application in the synthesis of steroid drugs. By optimizing the enzyme expression system, coenzyme NADH regeneration mechanism, high-density fermentation strategy and substrate feeding control, the present invention improves the biosynthesis efficiency of 9α-OH-AD, providing an industrializable technical solution for the green biomanufacture of steroid drugs. (2) Background Art
[0002] Steroid hormones are an important class of pharmaceutical products, known as the "key to life" due to their wide applications in treating various diseases such as rheumatism, cardiovascular diseases, neurodegenerative diseases (such as Alzheimer's disease), lymphocytic leukemia, anti-tumor, bacterial encephalitis, skin diseases, endocrine disorders, etc. Their global output value ranks second only to antibiotics.
[0003] 9α-Hydroxy-4-androstene-3,17-dione (9α-OH-AD) is an important precursor for the synthesis of steroid drugs. Due to its unique 9α-OH structure, it is commonly used in the synthesis of drugs with corticosteroid, anti-androgen, anti-estrogen and contraceptive functions (such as cortisone, hydrocortisone, betamethasone, dexamethasone, fluocinonide, triamcinolone, etc.). Existing chemical syntheses of steroid compounds have drawbacks such as harsh reaction conditions and the need to use expensive transition metal catalysts. Biotransformation technology, due to its mild conditions, simple steps, environmental friendliness, and few by-products, is expected to become a new way for the industrial green preparation of steroid compounds.
[0004] Microbial catalysis of steroid 9α-hydroxylation depends on 3-sterone-9α-hydroxylase (abbreviated as KSH). KSH is a two-component type IA monooxygenase composed of a Rieske oxidase (i.e., Ksh A subunit) and a ferredoxin reductase (i.e., Ksh B subunit). During the reaction, the electrons of NADH are transferred to the flavin cofactor (FAD) of Ksh B, and then transported to the [2Fe-2S] cluster of Ksh B. Ksh A receives the electrons from Ksh B, and the electrons finally reach the non-heme iron at the active site of Ksh A. The non-heme iron binds to O2 and is activated to catalyze the hydroxylation of the substrate. Due to the unique two-subunit structure of KSH, reasonable subunit interactions play an important role in the accurate and efficient progress of the reaction. In addition, due to the dependence of the reaction on coenzymes, the continuous consumption of coenzymes during the reaction will hinder the reaction process, and the continuous addition of coenzyme NADH will continuously increase the conversion cost. Therefore, obtaining a biocatalytic synthesis method with high catalytic efficiency and low conversion cost remains a difficult point in the biological preparation of steroid 9α-hydroxy compounds. (3) Summary of the Invention
[0005] The object of the present invention is to provide a dual-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase and its application in the preparation of steroid drugs. By optimizing the gene expression system, coenzyme NADH regeneration strategy, high-density fermentation combined with substrate feeding strategy, the efficient biocatalytic synthesis of 9α-OH-AD is achieved, and the key problems in the microbial catalytic synthesis of 9α-OH-AD from existing steroid compounds in industrial applications, such as low catalytic efficiency, high coenzyme cost, and inhibition of enzyme activity by high substrate concentration, are solved.
[0006] The technical solution adopted by the present invention is as follows:
[0007] The present invention provides a dual-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase for efficiently synthesizing 9α-OH-AD. The dual-enzyme coupled recombinant bacterium is constructed by transferring the Ksh A subunit gene RvKsh A of 3-sterone-9α-hydroxylase into the plasmid pET28a(+) to construct the recombinant plasmid pET28a(+)-RvKshA; then co-transferring the Ksh B subunit gene RvKsh B of 3-sterone-9α-hydroxylase and the formate dehydrogenase FDH gene into the plasmid pETDuet-1 to construct the recombinant plasmid pETDuet-1-RvKshB-FDH; finally, co-introducing the recombinant plasmids pETDuet-1-RvKshB-FDH and pET28a(+)-RvKshA into Escherichia coli to construct the described dual-enzyme coupled recombinant bacterium.
[0008] Furthermore, the nucleotide sequence of the gene RvKshA is as shown in SEQ ID NO.1, the nucleotide sequence of the gene RvKshB is as shown in SEQ ID NO.2, and the nucleotide sequence of the formate dehydrogenase FDH gene is as shown in SEQ ID NO.5.
[0009] Furthermore, the recombinant plasmid pETDuet-1-RvKshB-FDH is constructed by inserting the gene RvKshB between the PstI and XhoI restriction sites after the upstream T7 promoter of the plasmid pETDuet-1, and then ligating the formate dehydrogenase FDH gene between the NdeI and XhoI restriction sites after the downstream T7 promoter of the plasmid pETDuet-1; the recombinant plasmid pET28a(+)-RvKshA is constructed by inserting the gene RvKshA between the NdeI and XhoI restriction sites of the vector pET28a(+).
[0010] The present invention also provides an application of the dual-enzyme coupled recombinant bacterium of the 3-ketosteroid 9α-hydroxylase in catalyzing the synthesis of 9α-hydroxy-4-androstene-3,17-dione (9α-OH-AD) from 4-androstene-3,17-dione (AD).
[0011] Further, the application is as follows: using the wet cells obtained by induced expression of the dual-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase as a catalyst, using 4-androstene-3,17-dione as a substrate, using sodium formate as a co-substrate, using NAD + as a cofactor, using a phosphate buffer (PBS) with a pH of 6 - 8.5 (preferably pH 7.5) as a reaction medium to form a conversion system, reacting at 25 - 45°C (preferably 35°C) and 180 - 200 rpm for 6 - 30 h (preferably 24 h) to obtain 9α-OH-AD.
[0012] Further, in the conversion system, the final concentration of the substrate added is 10 - 80 mM (preferably 10 - 20 mM), the final concentration of the catalyst added is 20 - 80 g / L (preferably 50 g / L), NAD + is added at a final concentration of 25 - 150 mM (preferably 50 mM), and sodium formate is added at a final concentration of 0.5 - 7.5 mM (preferably 1.5 mM).
[0013] Further, the reaction medium is 10 mM PBS buffer (pH 7.4).
[0014] Further, the conversion system further contains a cosolvent with a volume concentration of 1 - 10% (preferably 4%), and the cosolvent includes dimethyl sulfoxide (DMSO), methanol, ethanol, isopropanol, and acetone.
[0015] Further, the conversion system further contains 20 g / L of cyclodextrin, and the cyclodextrin includes α-cyclodextrin, β-cyclodextrin, methyl-β-cyclodextrin, and hydroxypropyl-β-cyclodextrin.
[0016] Further, the conversion system contains metal ions at a final concentration of 0.5 mM, and the metal ions include Fe 2+ , Mn 2+ , preferably Fe 2+ .
[0017] Further, the catalyst is prepared as follows: inoculating the dual-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase into an LB liquid medium containing 50 μg / mL kanamycin and 50 μg / mL ampicillin, culturing at 37°C and 180 rpm for 12 h to obtain a seed solution; inoculating the seed solution into a TB liquid medium containing 50 μg / mL kanamycin and 50 μg / mL ampicillin at an inoculation amount of 3% (v / v), culturing in a shaker at 37°C and 180 rpm, when OD 600When it reaches 0.6 - 0.8, add IPTG to a final concentration of 0.1 mM, place it on a shaker at 20 °C and induce for 16 h. After the induction ends, centrifuge at 8000 rpm for 10 min to collect the wet bacterial cells; TB liquid medium: yeast extract 23.6 g / L, tryptone 11.8 g / L, glycerol 4 mL / L, dipotassium hydrogen phosphate 9.4 g / L, potassium dihydrogen phosphate 2.2 g / L, sterilize at 121 °C for 20 min.
[0018] Furthermore, the reaction is carried out in a fermenter according to the following steps:
[0019] Inoculate the double - enzyme - coupled recombinant bacterium of 3 - ketosteroid 9α - hydroxylase into LB medium, incubate at 37 °C and 180 - 200 rpm until the OD600 value reaches 1.6 - 1.8 to obtain a seed solution; inoculate the seed solution into a fermenter containing 2 L of fermentation medium at 4% (v / v), stir at 37 °C and 600 - 900 rpm, the aeration rate is 3 - 4 vvm, and the pH is maintained at 7.0; add supplementary medium through a flow system to maintain a dissolved oxygen level of 20% - 40%. When the OD600 value reaches 20, add IPTG with a final concentration of 0.5 mM, after inducing at 20 °C for 20 hours, add sodium formate and NADH to the fermenter, then add the substrate in batches, keep the temperature at 35 °C, the pH is 7.4, the stirring speed is 500 rpm, the aeration rate is 6 vvm, sample and detect every 24 h, and stop fermentation when the product amount no longer increases;
[0020] Composition of the fermentation medium: yeast extract 12.0 g / L, peptone 20.0 g / L, sodium chloride 1.0 g / L, (NH4)2SO4 6.0 g / L, MgSO4·7H2O 2.0 g / L, glycerol 7.5 g / L, 1 mL / L trace element solution, KH2PO4 3.0 g / L, Na2HPO4·12H2O 8.2 g / L, and 0.1% antifoaming agent, the solvent is water; Composition of the trace element solution: FeCl3·4H2O 22.87 g / L, ZnCl2 1.31 g / L, CoCl2·6H2O 2.0 g / L, CaCl2 0.76 g / L, CuCl2·2H2O 1.25 g / l, H3BO3 0.5 g / L, MnSO4·H2O 2.0 g / L, HCl 100 mL / L, the solvent is water;
[0021] Composition of the supplementary medium: yeast extract 10.0 g / L, glycerol 500.0 g / L, and vitamin C 0.45 g / L, the solvent is water.
[0022] Furthermore, the method of adding the substrate in batches is to first add AD with a final concentration of 10 - 20 mM, and then add 10 - 20 mM of AD every 3 - 7 hours.
[0023] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:
[0024] 1. Optimize the KSH expression system and improve the applicability of the catalytic system
[0025] The traditional KSH expression system has problems such as low expression level and enzyme instability, which affect its catalytic efficiency. The present invention constructs a dual plasmid co-expression system (pET28a+-RvKshA / pETDuet-1-RvKshB) to optimize the expression level of KSH, enabling its high-efficiency expression in Escherichia coli, providing a stable catalyst source for the catalytic synthesis of 9α-OH-AD.
[0026] 2. Improve the utilization efficiency of coenzyme NADH and reduce the catalytic cost
[0027] Since NADH is continuously consumed during the KSH-catalyzed 9α-hydroxylation reaction, the traditional process requires additional supplementation of NADH, resulting in a high cost. The present invention introduces formate dehydrogenase (FDH) and uses sodium formate as a co-substrate to achieve in vivo recycling and regeneration of NADH, reducing the dependence on exogenous NADH and making the catalytic system more economically feasible.
[0028] 3. Optimize the reaction system, reduce the generation of by-products, and improve the conversion rate
[0029] In the traditional microbial catalysis process, there are many by-products, which affect the purity of the target product and subsequent separation. The present invention optimizes the control strategies of pH, co-solvent, metal ions, and substrate concentration to ensure the stability of the catalytic process, reduce the generation of by-products, and increase the final conversion rate of 9α-OH-AD to 98.3%, significantly superior to the catalytic performance of a single KSH-expressing strain.
[0030] 4. Increase the cell concentration, achieve high-density fermentation, and improve the stability of the catalytic system
[0031] In the existing microbial catalytic system, due to the limitation of cell density, the overall conversion ability is low, making it difficult to meet the requirements of industrial production. The present invention optimizes the high-density fermentation process, and on the basis of controlling nutrient supply, oxygen solubility, and substrate accumulation, realizes large-scale cell culture, improves the overall stability and continuous catalytic ability of the catalytic system, significantly increases the production efficiency, and achieves a space-time yield of 42.8 mM / (L·day), showing significant industrial application prospects.
[0032] 5. Break through the problem of high substrate concentration inhibition and improve the substrate processing ability
[0033] Traditional microbial catalytic systems are vulnerable to inhibition at high substrate concentrations, leading to a decline in conversion efficiency. The present invention adopts a strategy of high-density fermentation combined with substrate feeding. By controlling the substrate concentration and feeding rate, the toxic effect of the substrate on cells is avoided, enabling the total substrate addition concentration to be increased to 80 mM, which is 4 times higher than the traditional method. Finally, the final concentration of 9α-OH-AD reaches 78.62 mM.
[0034] 6. An industrializable biocatalytic production system has been achieved
[0035] Due to the instability of the catalytic system and low substrate utilization rate of traditional microbial methods, it is difficult to directly apply them to industrial production. The present invention effectively improves the substrate adaptability and conversion ability of biocatalysis through a strategy of high-density fermentation combined with substrate feeding, making the catalytic process more stable and controllable, and providing an efficient and green technical solution for the industrial production of steroid drugs.
[0036] In summary, through dual-enzyme coupling, coenzyme NADH regeneration, high-density fermentation, and substrate feeding strategies, the present invention has broken through the bottleneck of the existing biocatalytic system, achieved an efficient, stable, and economical method for synthesizing 9α-OH-AD, and provided an efficient and feasible industrial solution for the biocatalytic production of steroid drugs. (IV) BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 It is a schematic diagram of the reaction mechanism for the generation of 9α-OH-AD by dual-enzyme coupling catalysis of AD.
[0038] Figure 2 It is a plasmid map and schematic diagram of a strain co-expressing the two subunits of 3-ketosteroid 9α-hydroxylase RvKshA and RvKshB.
[0039] Figure 3 It is a plasmid map and schematic diagram of a recombinant plasmid with the fusion expression of the two subunits of 3-ketosteroid 9α-hydroxylase RvKshA and RvKshB.
[0040] Figure 4 It is a plasmid map and schematic diagram of the dual-enzyme coupling of 3-ketosteroid 9α-hydroxylase and formate dehydrogenase.
[0041] Figure 5 It is an SDS-PAGE electrophoresis diagram of the co-expressed protein of RvKshA and RvKshB; where M is the protein molecular weight standard (Marker); lane 1 is the precipitate of the cell lysate of E. coli BL21-pET28a-RvKshA / pETDuet-1-RvKshB; lane 2 is the supernatant of the cell lysate of E. coli BL21-pET28a-RvKshA / pETDuet-1-RvKshB.
[0042] Figure 6SDS-PAGE electrophoresis pattern of the fusion expression protein of RvKshA and RvKshB, where M is the protein molecular weight standard (Marker); lane 1 is the precipitate of the cell lysate of E. coli BL21-pET28a-RvKshA-L-RvKshB; lane 2 is the supernatant of the cell lysate of E. coli BL21-pET28a-RvKshA-L-RvKshB; lane 3 is the precipitate of the cell lysate of E. coli BL21-pET28a(+)-RvKshB-L-RvKshA; lane 4 is the supernatant of the cell lysate of E. coli BL21-pET28a(+)-RvKshB-L-RvKshA.
[0043] Figure 7 SDS-PAGE electrophoresis pattern of the protein of the double-enzyme coupled recombinant strain of 3-ketosteroid 9α-hydroxylase and formate dehydrogenase; where M is the protein molecular weight standard (Marker); lane 1 is the precipitate of the cell lysate of E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH; lane 2 is the supernatant of the cell lysate of E. coli BL21-pET28a-RvKshA / pETDuet-1-RvKshB-FDH.
[0044] Figure 8 Column chart of the substrate conversion rate for optimizing the whole-cell catalytic reaction conditions of recombinant Escherichia coli E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH. Among them, (a) is pH, (b) is the reaction time, (c) is the reaction temperature, (d) is the concentration of sodium formate, (e) is the concentration of NADH, (f) is metal ions, (g) is the co-solvent, (h) is cyclodextrin, and (i) is the substrate concentration.
[0045] Figure 9 Line chart of the conversion rate of in-situ production of 9α-OH-AD by high-density fermentation of recombinant Escherichia coli E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH combined with the strategy of batch feeding of the substrate. Among them, (a) is the batch addition of the substrate, and (b) is the batch addition of the substrate. (V) Specific implementation manners
[0046] The present invention will be further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto. Based on the embodiments described in the present invention, all other embodiments made by those skilled in the art without creative labor should be included in the protection scope of the present invention:
[0047] Unless otherwise specified, the reagents and equipment used in each example are commercially available.
[0048] The culture media involved in the specific embodiments of the present invention:
[0049] LB liquid medium: Tryptone 10 g / L, NaCl 10 g / L, Yeast extract 5 g / L, pH 7.0, sterilized at 121 °C for 20 min. LB solid medium is LB liquid medium added with 20 g / L agar powder.
[0050] TB liquid medium: Yeast extract 23.6 g / L, Tryptone 11.8 g / L, Glycerol 4 mL / L, Dipotassium hydrogen phosphate 9.4 g / L, Potassium dihydrogen phosphate 2.2 g / L, sterilized at 121 °C for 20 min.
[0051] Example 1: Construction of a co-expression strain of 3-ketosteroid 9α-hydroxylase RvKshA and RvKshB
[0052] Using the REME reaction enzyme mining and evaluation platform, the potential 3-ketosteroid 9α-hydroxylase was mined with the conversion of 4-androsten-3,17-dione (AD) to 9α-OH-AD as the model reaction. The successfully mined fragments annotated as "3-Ketosteroid9alpha-hydroxylase C-terminal domain" (Protein ID: WP_003419211.1) and "3-ketosteroid-9-alpha-hydroxylase reductase subuni" (Protein ID: WP_003900102.1) from Mycobacterium in NCBI were respectively entrusted to Tsingke Biotechnology Co., Ltd. for codon optimization and synthesis, denoted as RvKshA and RvKshB respectively, and the nucleotide sequences are shown in SEQ ID NO.1 and SEQ ID NO.2 respectively.
[0053] The gene RvkshA was inserted between the NdeI and XhoI restriction sites of the pET28a(+) vector carrying the T7 promoter and the lac operon, thereby obtaining the recombinant plasmid pET28a(+)-RvKshA with an N-terminal T7 promoter, a lac operon and an in-frame C-terminal 6-His tag. The nucleotide sequences of the T7 promoter and the lac operon are shown in SEQ ID NO.6, where 1-20 bp represents the T7 promoter.
[0054] The gene RvkshB was inserted between the PstI and XhoI restriction sites downstream of the T7 promoter in plasmid pETDuet-1 to obtain the recombinant plasmid pETDuet-1-RvKshB.
[0055] The recombinant plasmids pET28a+-RvKshA and pETDuet-1-RvKshB were co-introduced into Escherichia coli BL21(DE3) to obtain the co-expressing recombinant Escherichia coli E.coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB. The plasmid map is shown in Figure 2 .
[0056] Structural formula of 4-androsten-3,17-dione:
[0057]
[0058] Example 2: Construction of a strain for the fusion expression of the two subunits of 3-ketosteroid 9α-hydroxylase RvKshA and RvKshB
[0059] 1. E.coli BL21-pET28a(+)-RvKshA-L-RvKshB
[0060] The recombinant plasmids pET28a+-RvKshA and pETDuet-1-RvKshB constructed in Example 1 were respectively introduced into Escherichia coli BL21(DE3) to obtain the recombinant Escherichia coli E.coli BL21-pET28a(+)-RvKshA and E.coli BL21-pETDuet-1-RvKshB.
[0061] The above recombinant Escherichia coli containing the plasmids of RvKshA subunit and RvKshB subunit were respectively cultured overnight at 37 °C in LB liquid medium, and then the plasmids pET28a(+)-RvKshA and pETDuet-1-RvKshB were extracted.
[0062] Using the plasmids pET28a(+)-RvKshA and pETDuet-1-RvKshB DNA as templates respectively, and the primers with the linker peptide G4S shown in Table 1, the target genes RvKshA-L and L-RvKshB with the flexible linker peptide G4S (GGGGS, corresponding base sequence is GGAGGAGGAGGATCT) were amplified by PCR.
[0063] PCR System 1: 2 μL of pET28a(+)-RvKshA plasmid DNA, 2 μL of 28af-RvA-F, 2 μL of 28af-RvA-R, 25 μL of 2×Hieff Canace PCR Master Mix, 19 μL of ddH2O. Recover the target gene RvKshA.
[0064] PCR System 2: 2 μL of pETDuet-1-RvKshB plasmid DNA, 2 μL of 28af-RvB-F, 2 μL of 28af-RvB-R, 25 μL of 2×Hieff Canace PCR Master Mix, 19 μL of ddH2O. Recover the target gene L-RvKshB.
[0065] The amplification program is: pre-denaturation at 94°C for 5 min, denaturation at 94°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 45 s, 35 cycles, final extension at 72°C for 10 min, and incubation at 4°C.
[0066] The plasmid pET-28a(+) was digested with NdeI and XbaI. The digestion products were analyzed by agarose gel electrophoresis and the gel was cut and recovered to obtain the linearized vector NdeI-pET-28a(+)-XbaI. The purified PCR products RvKshA-L and L-RvKshB were mixed with the linearized vector NdeI-pET-28a(+)-XbaI at a molar ratio of 3:1. The target genes were ligated into the expression vector pET28a(+) using a seamless cloning kit. The ligation products were transformed into Escherichia coli DH5α, and the recombinant plasmids were verified by sequencing. The correctly identified recombinant plasmids were named pET28a(+)-RvKshA-L-RvKshB. Finally, these plasmids were transformed into the Escherichia coli BL21(DE3) host to obtain the fusion expression recombinant bacterium E.coli BL21-pET28a(+)-RvKshA-L-RvKshB. The nucleotide sequence of RvKshA-L-RvKshB is shown in SEQ ID NO.3, and the map is shown in Figure 3 。
[0067] 2. E.coli BL21-pET28a(+)-RvKshB-L-RvKshA
[0068] Using the same method as above, the primers in PCR System 1 and PCR System 2 were replaced to obtain the fusion expression recombinant bacterium E.coli BL21-pET28a(+)-RvKshB-L-RvKshA. The nucleotide sequence of RvKshB-L-RvKshA is shown in SEQ ID NO.4.
[0069] Table 1. Primers used in PCR (the underline represents the linker peptide)
[0070]
[0071] Example 3: Comparison of the conversion ability of co-expressing and fusion-expressing recombinant bacteria to AD
[0072] (1) Preparation of biocatalyst
[0073] The co-expressing recombinant bacteria and fusion-expressing recombinant bacteria constructed in Examples 1 and 2 were respectively inoculated onto LB slant medium and cultured overnight at 37°C, and then inoculated into 50 mL of LB liquid medium and cultured overnight at 37°C and 200 rpm. The culture broth was inoculated into 100 mL of TB liquid medium at a volume concentration of 3% and cultured at 37°C and 200 rpm until the optical density (OD600) at a wavelength of 600 nm reached 0.6 - 0.8. At this time, isopropyl β-D-thiogalactoside (IPTG) with a final concentration of 0.5 mM was added, and the culture was further cultured at 20°C for 16 hours. Then, it was centrifuged at 8000 rpm for 10 min, and the wet cells were collected as the catalyst.
[0074] (2) Verification of protein expression using SDS-PAGE
[0075] The wet cells collected by centrifugation were resuspended in 50 mM PBS (pH 7.4) buffer at a concentration of 100 g / L to obtain a resting cell suspension. After ultrasonic disruption for 15 minutes (power 400 W, intermittent for 2 seconds, working for 3 seconds), the disrupted solution was centrifuged at 8000 rpm and 4°C for 10 min to obtain the supernatant and precipitate of proteins RvKshA and RvKshB respectively. The successful overexpression of proteins RvKshA and RvKshB was verified by SDS-PAGE protein electrophoresis, and the results are shown in Figure 5, The specific method is as follows: The first step is leak detection. Assemble the gel maker and conduct leak detection with distilled water. If there is no liquid leakage after standing for 10 minutes, it proves good sealing performance. The second step is gel preparation. Prepare the separating gel and quickly add it to the gel tank. Take an appropriate amount of isopropanol and add it above the separating gel to isolate air and keep the gel surface flat. Add the stacking gel and insert the comb to prepare gel holes, and let it stand for 30 - 50 minutes until the gel solidifies. After the gel solidifies, take out the gel plate and place it in the electrophoresis tank. Add sufficient electrophoresis buffer and then pull out the comb. The third step is electrophoresis. Add the sample and protein Marker, run at 90 V for 15 minutes, and then run at 120 V for 90 minutes to end. The fourth step is staining and decolorization. After taking out the protein gel, add the staining solution (dissolve 1 g of Coomassie Brilliant Blue R250 in 100 mL of glacial acetic acid, 450 mL of methanol, and 450 mL of deionized water), stain in a 50 °C water bath for 15 minutes. After washing off the floating color with water, add the decolorizing solution (fully mix 140 mL of ethanol, 60 mL of glacial acetic acid, and 800 mL of deionized water), and decolorize in a 50 °C water bath for 2 - 4 times, 15 minutes each time.
[0076] The same method was used to verify the successful overexpression of the fusion proteins RvKshA-L-RvKshB and RvKshB-L-RvKshA by SDS-PAGE. The results are shown in Figure 6 .
[0077] (3) Whole-cell catalytic reaction
[0078] The final concentration composition of the whole-cell catalytic reaction system (volume 10 mL): 10 mM AD, 50 g / L wet cell mass, 1.5 mM sodium formate, and 0.1 mM NADH. Place it in 50 mM PBS buffer (pH 7.4) to form a 10 mL reaction system, and react at 35 °C and 180 rpm for 24 hours. Subsequently, centrifuge the reaction mixture, extract the supernatant three times with an equal volume of ethyl acetate, then rotary evaporate and dry the ethyl acetate layer. Dissolve the product in 20 μL of methanol, filter it through a 0.22 μm organic phase filter membrane, and analyze the substrate conversion rate of the filtrate by liquid chromatography.
[0079] (4) Substrate and product analysis
[0080] Use a Shimadzu LC-2014 liquid chromatograph and a Yuexu XB-C18 (4.6 * 250 mm, 5 μm) reverse chromatographic column. The mobile phase is methanol: water = 8:2 (v / v); the flow rate is 0.8 mL / min, the ultraviolet detection wavelength is 254 nm, and the injection volume is 10 μL.
[0081]
[0082] In formula (1), Mp: the molar concentration of the substrate at the end of the reaction, mol / L; Ms: the molar concentration of the substrate at the beginning of the reaction, mol / L.
[0083] Table 2. Whole-cell catalytic conversion rates of fusion expression and co-expression
[0084] Strain Conversion rate (%) E.coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB 51.64±0.51 E.coli BL21-pET28a(+)-RvKshA-L-RvKshB 33.76±0.61 E.coli BL21-pET28a(+)-RvKshB-L-RvKshA 26.4±0.37
[0085] As can be seen from Table 2 above, there are significant differences in the performance of different RvKshA-RvKshB expression systems in the whole-cell catalytic reaction. Among the fusion-expression recombinant strains, the recombinant bacterium E. coli BL21-pET28a(+)-RvKshA-L-RvKshB with RvKshA at the N-terminus showed higher catalytic efficiency. Compared with the recombinant bacterium E. coli BL21-pET28a(+)-RvKshB-L-RvKshA with RvKshB at the N-terminus, the conversion rates reached approximately 33.76% and 26.4% respectively after 24 hours. This result indicates that the preferential expression of RvKshA may be more conducive to maintaining its active structure, thereby enhancing the efficiency of initial substrate processing and providing a more stable intermediate product for RvKshB to support subsequent reactions. The catalytic performance of the dual-plasmid co-expression strain E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB was the most excellent, and the conversion rate after 24 hours reached 51.64%, which was the highest among all recombinant strains. This result shows that the dual-plasmid system can significantly improve the synergy of the enzymes by independently regulating the expression levels of RvKshA and RvKshB, avoiding the expression imbalance problem that may occur in the single-plasmid system.
[0086] Example 4: Construction of a recombinant bacterium with dual-enzyme coupling of 3-ketosteroid 9α-hydroxylase RvKSH and FDH
[0087] The fragment from [Candida] boidinii in NCBI annotated as "NAD-dependent Formate Dehydrogenase (FDH)" (GenBank: OWB80117.1) was entrusted to Tsingke Company for codon optimization and synthesis, denoted as the formate dehydrogenase fdh gene, and its nucleotide sequence is as shown in SEQ ID NO.5.
[0088] To construct a recombinant strain co-expressing FDH and KSH, the fdh gene was cloned downstream of the T7 promoter of the plasmid pETDuet-1-RvkshB constructed in Example 1 to obtain the plasmid pETDuet-1-RvkshB-FDH. The plasmids pET28a(+)-RvKshA and pETDuet-1-RvkshB-FDH constructed in Example 1 were co-transformed into the Escherichia coli BL21(DE3) host, inoculated into an LB solid medium containing 50 μg / mL ampicillin and 50 μg / mL kanamycin, cultured overnight at 37 °C, and the strain with both ampicillin and kanamycin resistance was screened, which was the strain containing the plasmid co-expressing KSH and FDH. The double-enzyme conjugate recombinant bacterium E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH was obtained. The map and construction process are shown in Figure 4 .
[0089] Example 5: Biotransformation of 9α-OH-AD by double-enzyme conjugate recombinant bacterium
[0090] The glycerol stock solution of E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH was inoculated into 20 mL of an LB liquid medium containing 50 μg / mL kanamycin and 50 μg / mL ampicillin, cultured at 37 °C and 180 rpm for 12 h to obtain a seed solution. The seed solution was inoculated into 100 mL of a TB liquid medium containing 50 μg / mL kanamycin and 50 μg / mL ampicillin at an inoculation amount of 3% (v / v), and cultured on a shaker at 37 °C and 180 rpm. When the OD 600 reached 0.6 - 0.8, IPTG was added to a final concentration of 0.1 mM, and the mixture was placed on a shaker at 20 °C for induction for 16 h. After the induction was completed, the wet cells were collected by centrifugation at 8000 rpm for 10 min, and washed with 0.9% (w / v) physiological saline to remove residual culture medium components and other impurities.
[0091] To verify that the proteins RvKshA, RvKshB, and FDH were all overexpressed, the wet cells harvested by centrifugation after the induction was completed were resuspended in a 50 mM PBS (pH 7.4) buffer at a concentration of 100 g / L to obtain a resting cell suspension. Ultrasonic disruption was performed for 15 minutes (power 400 W, intermittent for 2 seconds, working for 3 seconds), and the disrupted solution was centrifuged at 8000 rpm and 4 °C for 10 min to obtain the supernatant and precipitate respectively. SDS-PAGE protein electrophoresis detection was performed using the method of Example 3, and the results are shown in Figure 7 , and the results showed that the proteins RvKshA, RvKshB, and FDH were all overexpressed.
[0092] The collected wet bacterial cells were resuspended in 50 mM PBS (pH 7.4) buffer, and 20 mM AD, 50 g / L wet cells, 1.5 mM sodium formate and 0.1 mM NADH were added. The reaction system was made up to 10 mL with 50 mM PBS buffer (pH 7.4). The amount of wet bacterial cells added was 50 g / L, and the reaction was carried out at 35 °C and 180 rpm for 24 hours. After the reaction, extraction was performed three times with an equal volume of ethyl acetate. After the extract was dried by rotation, it was redissolved with methanol and analyzed by liquid chromatography as described in Example 4. Under the same conditions, the wet bacterial cells prepared from the recombinant bacterium E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB were used as a control.
[0093] By liquid chromatography analysis, for E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH, the conversion rate of AD reached 86.3% under 20 mM substrate, which was significantly better than 51% of the recombinant bacterium E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB without a coenzyme regeneration system.
[0094] Example 6: Optimization of the reaction conditions for whole-cell catalysis by a dual-enzyme coupled recombinant bacterium
[0095] The purpose of this example was to investigate the effects of various parameters on the catalytic efficiency and productivity of the whole microbial cell-catalyzed hydroxylation reaction of steroid compounds at the 9-position. The whole cells of the dual-enzyme coupled recombinant bacterium E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH from Example 5 were used as the catalyst, and the molar conversion rate of the substrate was used as the index. The parameters for the hydroxylation of AD to 9α-OH-AD were optimized individually using the "one parameter at a time" method, that is, other parameters were kept constant except for the parameter being studied.
[0096] 1. pH
[0097] The final concentration composition of the 10 mL reaction system: 10 mM AD, 50 g / L wet bacterial cells, 1.5 mM sodium formate and 0.1 mM NADH were placed in 50 mM PBS buffer (pH 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9) to form a 10 mL reaction system, and the reaction was carried out at 35 °C and 180 rpm for 24 hours. The method of Example 4 was used to detect the substrate conversion rate, and the results are shown in Figure 8 a. The conversion rate was the highest at pH 7.5, reaching 92.3%, indicating that a neutral to weakly alkaline environment is beneficial to enzyme activity.
[0098] 2. Reaction time
[0099] Fix the pH in item 1 above at 7.4, change the reaction time to 4, 8, 12, 16, 20, 24, 30, 36 h, keep other operations the same, and the results are shown in Figure 8 b in [reference], the conversion rate gradually increases with the prolongation of the reaction time and reaches equilibrium and remains stable at 24 h.
[0100] 3. Reaction temperature
[0101] Fix the pH in item 1 above at 7.4, change the reaction temperature to 25, 30, 35, 40, 45 °C, keep other operations the same, and the results are shown in Figure 8 c in [reference], the conversion rate is the highest at 35 °C (92.4%), but it decreases significantly after the temperature exceeds 40 °C, probably due to the thermal sensitivity and partial inactivation of enzyme activity.
[0102] 4. Sodium formate concentration
[0103] Fix the pH in item 1 above at 7.4, change the sodium formate concentration to 0, 0.5, 1, 1.5, 2, 2.5, 5, 7.5 mM, keep other operations the same, and the results are shown in Figure 8 d in [reference], the optimal conversion rate is achieved at a concentration of 2 mM, and further increasing the concentration has no significant effect on the reaction, indicating that this concentration already meets the coenzyme regeneration requirement.
[0104] 5. NADH concentration
[0105] Fix the pH in item 1 above at 7.4, change the NADH concentration to 0, 25, 50, 75, 100, 150 mM, keep other operations the same, and the results are shown in Figure 8 e in [reference], the conversion rate increases significantly with the increase of NADH concentration, reaches the maximum at 50 mM, and then remains stable, indicating that this concentration can fully drive the reaction.
[0106] 6. Metal ions
[0107] Fix the pH in item 1 above at 7.4, add metal ions (K + , Mg 2+ , Ca 2+ , Fe 2+ , Zn 2+ , Mn 2+ , with the blank as the control) at a final concentration of 0.5 mM, keep other operations the same, and the results are shown in Figure 8 f in [reference], Fe 2+ significantly promotes the enzyme activity, making the conversion rate reach 96.8%, while Ca 2+ and Cu 2+ show inhibitory effects on the enzyme, and their conversion rates are 85.3% and 84.2% respectively, significantly lower than the blank control, probably due to interfering with the active center of the enzyme.
[0108] 7. Cosolvent
[0109] Fix the pH in item 1 above at 7.4, and add cosolvents (DMSO, methanol, ethanol, isopropanol, acetone) at volume concentrations of 2%, 4%, and 6% respectively. Other operations are the same. The results are shown in Figure 8 g. Adding 4% DMSO can significantly improve the substrate solubility and increase the reaction conversion rate to 98.3%, which is better than other solvents (such as methanol and ethanol). The latter may reduce the conversion rate due to the interference with the enzyme structure stability.
[0110] 8. Cyclodextrin
[0111] Fix the pH in item 1 above at 7.4, and add 20 g / L cyclodextrin (α-cyclodextrin α-CD, β-cyclodextrin β-CD, methyl-β-cyclodextrin Me-β-CD, hydroxypropyl-β-cyclodextrin HP-β-CD). Other operations are the same. The results are shown in Figure 8 h. Methyl-β-cyclodextrin has the most significant improvement in the conversion rate, reaching 96.3%. It effectively reduces the inhibitory effect of the substrate on the enzyme by improving the substrate solubility.
[0112] 9. Substrate concentration
[0113] Fix the pH in item 1 above at 7.4, and change the substrate concentration to 10 mM, 20 mM, 30 mM, 40 mM, 50 mM, 60 mM. Other operations are the same. The results are shown in Figure 8 i. The conversion rate is the highest at a concentration of 10 mM, which is 99.1%. When the concentration increases to 20 mM, the conversion rate also remains at a relatively high level, which is 95.9%. However, as the substrate concentration further increases, the conversion rate shows a significant decrease. This may be due to the inhibitory effect of the high-concentration substrate on the enzyme or insufficient substrate solubility.
[0114] Figure 8 It shows that the optimized best catalytic conditions are: pH 7.5, temperature 35 °C, reaction time 24 h, wet cell mass 50 g / L, sodium formate concentration 2 mM, NADH concentration 50 mM, adding 4% (v / v) DMSO and 20 g / L of β-cyclodextrin to improve the substrate solubility. Under these optimized conditions, the conversion rate of the dual-enzyme coupled recombinant bacterium E. coli BL21-pET28a+-RvKshA / pETDuet-1-RvKshB-FDH whole cells to 20 mM AD is 98.3%.
[0115] Example 7: Synthesis of 9α-OH-AD by high-density fermentation combined with substrate feeding strategy
[0116] The purpose of this example is to improve the substrate conversion efficiency and yield of the recombinant strain E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH. In the research, the whole cells of the double-enzyme coupled recombinant strain E. coli BL21-pET28a(+)-RvKshA / pETDuet-1-RvKshB-FDH from Example 5 were used as catalysts, and a high-density fermentation strategy combined with a substrate feeding strategy was adopted for whole-cell catalysis. Under constant dissolved oxygen conditions, continuous nutrient supplementation was promoted by a fed-batch system, resulting in an increase in cell density and a significant improvement in enzyme activity. The specific fermentation process is as follows:
[0117] The double-enzyme coupled recombinant strain preserved with glycerol was inoculated into a conical flask containing 100 mL of LB medium and incubated at 37 °C and 180 rpm until the OD600 value reached 1.6 to obtain a seed solution. The seed solution was inoculated into a 5 L fermenter containing 2 L of fermentation medium at 4% (v / v), stirred at 37 °C and 900 rpm, with an aeration rate of 3 vvm, and the pH was maintained at 7.0. The supplementary medium was added through a flow system to maintain a dissolved oxygen level of 30%. When the OD600 value reached 20, IPTG with a final concentration of 0.5 mM was added and induced at 20 °C for 20 hours.
[0118] After 20 hours of induction, the cell concentration reached 80 g / L, and the substrate and cosubstrate (sodium formate) were added to the fermenter. The temperature was maintained at 35 °C, the pH was 7.4, the stirring speed was 500 rpm, and the aeration rate was 6 vvm. The substrate addition strategy was optimized to improve the conversion rate of 9α-OH-AD:
[0119] Substrate batch addition method: A total of 40 mM of AD, 1.5 mM of sodium formate, and 50 mM of NADH were added to the fermenter at one time. After reacting for 16 h, the final concentration of 9-OH-AD was 38.78 mM. The results are shown in Figure 9 a in
[0120] Substrate fed-batch addition method: 20 mM of AD, 1.5 mM of sodium formate, and 50 mM of NADH were initially added. Then, 20 mM of AD was added every 5 hours, and the total addition amount reached 80 mM (when the substrate concentration was higher than 80 mM, the change in substrate conversion rate was small). After 22 hours, the final concentration of 9-OH-AD was 78.62 mM, which was 1.5 times higher than that of the batch addition method. The results are shown in Figure 9 b in. The conversion rate of AD was as high as 98.3%, and the spatiotemporal yield reached 42.8 mM / (L·day), which was approximately 16.6 times higher than that of the traditional shake-flask fermentation in Example 6.
[0121] High-density fermentation combined with substrate feeding strategy effectively avoids the inhibition of enzyme activity by high substrate concentration, enables the cells to maintain high catalytic ability under high-density conditions, and finally realizes the efficient conversion of 80 mM AD. Compared with traditional shake-flask fermentation that can only handle 20 mM substrate, it breaks through the limitation of high substrate concentration on enzymes.
[0122] Composition of fermentation medium: 12.0 g / L yeast extract, 20.0 g / L peptone, 1.0 g / L sodium chloride, 6.0 g / L (NH4)2SO4, 2.0 g / L MgSO4·7H2O, 7.5 g / L glycerol, 1 mL / L trace element solution, 3.0 g / L KH2PO4, 8.2 g / L Na2HPO4·12H2O, and 0.1% antifoaming agent, with water as the solvent. Composition of trace element solution: 22.87 g / L FeCl3·4H2O, 1.31 g / L ZnCl2, 2.0 g / L CoCl2·6H2O, 0.76 g / L CaCl2, 1.25 g / L CuCl2·2H2O, 0.5 g / L H3BO3, 2.0 g / L MnSO4·H2O, 100 mL / L HCl, with water as the solvent.
[0123] Composition of supplementary medium: 10.0 g / L yeast extract, 500.0 g / L glycerol, and 0.45 g / L vitamin C, with water as the solvent.
Claims
1. A dual-enzyme coupled recombinant bacterium for 3-ketosteroid 9α-hydroxylase for efficiently synthesizing 9α-OH-AD, characterized in that, The double-enzyme coupled recombinant bacterium is constructed by transferring the Ksh A subunit gene RvKshA of 3-sterone-9α-hydroxylase into the plasmid pET28a(+) to construct the recombinant plasmid pET28a(+)-RvKshA; then co-transferring the subunit Ksh B gene RvKshB of 3-sterone-9α-hydroxylase and the formate dehydrogenase FDH gene into the plasmid pETDuet-1 to construct the recombinant plasmid pETDuet-1-RvKshB-FDH; finally, co-introducing the recombinant plasmids pETDuet-1-RvKshB-FDH and pET28a(+)-RvKshA into Escherichia coli to construct the described double-enzyme coupled recombinant bacterium.
2. The dual-enzyme conjugate recombinant bacterium according to claim 1, wherein The nucleotide sequence of the gene RvKshA is shown as SEQ ID NO.1, the nucleotide sequence of the gene RvKshB is shown as SEQ ID NO.2, and the nucleotide sequence of the formate dehydrogenase FDH gene is shown as SEQ ID NO.
5.
3. The dual-enzyme conjugate recombinant bacterium according to claim 1, wherein, The recombinant plasmid pETDuet-1-RvKshB-FDH is constructed by inserting the gene RvKshB between the PstI and XhoI restriction sites after the upstream T7 promoter of the plasmid pETDuet-1, and then ligating the formate dehydrogenase FDH gene between the NdeI and XhoI restriction sites after the downstream T7 promoter of the plasmid pETDuet-1; the recombinant plasmid pET28a(+)-RvKshA is constructed by inserting the gene RvKshA between the NdeI and XhoI restriction sites of the vector pET28a(+).
4. Application of the double-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase described in claim 1 in catalyzing the synthesis of 9α-hydroxy-4-androstene-3,17-dione from 4-androstene-3,17-dione.
5. The application according to claim 4, characterized in that, The application is as follows: using the wet cells obtained by induced expression of the double-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase as a catalyst, using 4-androstene-3,17-dione as a substrate, using sodium formate as a co-substrate, using NAD + as a cofactor, using a phosphate buffer solution with a pH of 6 - 8.5 as a reaction medium to form a conversion system, reacting under the conditions of 25 - 45 °C and 180 - 200 rpm for 6 - 30 h to obtain 9α-hydroxy-4-androstene-3,17-dione.
6. The application according to claim 5, wherein In the conversion system, the final concentration of the substrate added is 10 - 80 mM, the final concentration of the catalyst added is 20 - 80 g / L, NAD + is added at a final concentration of 25 - 150 mM, and sodium formate is added at a final concentration of 0.5 - 7.5 mM.
7. The application according to claim 5, characterized in that, The transformation system contains a cosolvent with a volume concentration of 1-10%, and the cosolvent includes dimethyl sulfoxide, methanol, ethanol, isopropanol, and acetone.
8. The application according to claim 5, characterized in that The transformation system contains 20 g / L of cyclodextrin, and the cyclodextrin includes α-cyclodextrin, β-cyclodextrin, methyl-β-cyclodextrin, and hydroxypropyl-β-cyclodextrin.
9. The application according to claim 5, wherein The conversion system contains metal ions with a final concentration of 0.5 mM, and the metal ions include Fe 2 +, Mn 2+ .
10. The application according to claim 5, wherein, The reaction is carried out in a fermenter according to the following steps: Inoculate the double-enzyme coupled recombinant bacterium of 3-ketosteroid 9α-hydroxylase into LB medium, incubate at 37 °C and 180 - 200 rpm until the OD600 value reaches 1.6 - 1.8 to obtain a seed solution; inoculate the seed solution into a fermenter containing 2 L of fermentation medium at a volume concentration of 4%, stir at 37 °C and 600 rpm - 900 rpm, the aeration rate is 3 - 4 vvm, and the pH is maintained at 7.0; add supplementary medium through a flow system to maintain a dissolved oxygen level of 20% - 40%. When the OD600 value reaches 20, add IPTG with a final concentration of 0.5 mM, induce at 20 °C for 20 hours, then add sodium formate and NADH to the fermenter, and add the substrate in batches. Keep the temperature at 35 °C, the pH at 7.4, the stirring speed at 500 rpm, and the aeration rate at 6 vvm. Take samples for detection every 24 h, and stop fermentation when the product no longer increases; the method of adding the substrate in batches is to first add the substrate with a final concentration of 10 - 20 mM, and supplement 10 - 20 mM of the substrate every 3 - 7 hours. Composition of the fermentation medium: 12.0 g / L yeast extract, 20.0 g / L peptone, 1.0 g / L sodium chloride, 6.0 g / L (NH4)2SO4, 2.0 g / L MgSO4·7H2O, 7.5 g / L glycerol, 1 mL / L trace element solution, 3.0 g / L KH2PO4, 8.2 g / L Na2HPO4·12H2O, and 0.1% antifoaming agent, with water as the solvent; Composition of the trace element solution: 22.87 g / L FeCl3·4H2O, 1.31 g / L ZnCl2, 2.0 g / L CoCl2·6H2O, 0.76 g / L CaCl2, 1.25 g / L CuCl2·2H2O, 0.5 g / L H3BO3, 2.0 g / L MnSO4·H2O, 100 mL / L HCl, with water as the solvent. Composition of the supplementary medium: 10.0 g / L yeast extract, 500.0 g / L glycerol, and 0.45 g / L vitamin C, with water as the solvent.
